Extension Study of Hetrombopag in Severe Aplastic Anemia
Clinical trial NCT04961710 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04961710
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2024-11-30
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.